Recent studies have also started investigating the impact of protein S-palmitoylation on the regulation of the tumor immune microenvironment, particularly in relation to IFN-γ and PD-1/PD-L1 signaling (Figure 3) (33). The gene discussed is IFNG; the disease is neoplasm.